Literature DB >> 11328381

Immune responses in tuberculosis: antibodies and CD4-CD8 lymphocytes with vascular adhesion molecules and cytokines (chemokines) cause a rapid antigen-specific cell infiltration at sites of bacillus Calmette-Guérin reinfection.

T Shigenaga1, A M Dannenberg, D B Lowrie, W Said, M J Urist, H Abbey, B H Schofield, P Mounts, K Sugisaki.   

Abstract

Rabbit primary dermal bacillus Calmette-Guérin (BCG) lesions were compared with reinfection BCG lesions in order to gain insight into how immune responses protect against clinical tuberculosis. As early as 3 hr, a marked infiltration of macrophages and lymphocytes occurred in the reinfection group, while very little cell infiltration occurred in the primary group. It seems that only an antigen-antibody reaction could produce such an immediate pronounced antigen-specific chemotactic effect, because very few lymphocytes are normally present in the skin. Therefore, antibodies hasten the accumulation of an expanded antigen-specific T-lymphocyte population (memory cells) at sites of bacillary lodgement. By 1-2 days, the primary and reinfection BCG lesions differed 400- to 500-fold in size. By 4-5 days, the size of the reinfection lesions had declined, while the size of the primary lesions had increased, so that, grossly, both types of lesion were similar. At 8 days in reinfection lesions and at 12 days in primary lesions, small secondary peaks in size occurred, which were probably caused by cell-mediated immune responses. In rabbits with primary BCG lesions, skin tests with Old Tuberculin were positive at 9 days, accompanied by a rise in the levels of antibodies to the secreted antigen, phosphate-specific transport protein 1, but the levels of antibodies to the constitutive antigens, purified protein derivative and heat-shock protein 65, did not increase appreciably until some time after 23 days. In tissue sections of reinfection BCG lesions, the percentage of mononuclear cells labelled, by in situ hybridization techniques, for the mRNA of monocyte chemoattractant protein 1 (MCP-1), a chemokine, peaked at 3 hr and then was down-regulated, whereas in primary lesions, this percentage was down-regulated only after 2 days. [The percentage in the tissue sections for the mRNAs of interleukins 1beta and 8, as well as the proteins of MCP-1 and tumor necrosis factor alpha (TNF-alpha), followed a somewhat similar time-course to that of MCP-1 mRNA.] A high percentage of mononuclear cells containing the MCP-1 mRNA 'factory' would favour enlargement of the lesions and a low percentage would favour their regression. At 5 days, the percentage of CD4 and CD8 lymphocytes, stained by immunohistochemical techniques, and the amount of microvasculature stained similarly for vascular cell adhesion molecule 1 were higher in the reinfection group, indicating that prior immunization caused a more rapid (antigen-dependent) up-regulation of these factors. Tuberculin reactions resembled early reinfection BCG lesions in almost every factor evaluated herein. In brief, the production of chemokines began soon after BCG reinfection, peaked within a few hours and was markedly down-regulated by 24 hr, a time at which the lesions of reinfection were of maximal size. Therefore, the amount of cell infiltration was tightly controlled, probably by the variety of mechanisms listed herein.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11328381      PMCID: PMC1783201          DOI: 10.1046/j.1365-2567.2001.01195.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  61 in total

1.  Paradox of the global emergency of tuberculosis.

Authors:  J M Grange; A Zumla
Journal:  Lancet       Date:  1999-03-20       Impact factor: 79.321

2.  The pattern of mycobacterial antigen recognition in sera from Mantoux-negative individuals is essentially unaffected by bacille Calmette-Guérin (BCG) vaccination in either south India or London.

Authors:  S Das; S H Cheng; D B Lowrie; K B Walker; D A Mitchison; R S Vallishayee; P R Narayanan
Journal:  Clin Exp Immunol       Date:  1992-09       Impact factor: 4.330

3.  Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis.

Authors:  M I Cybulsky; M A Gimbrone
Journal:  Science       Date:  1991-02-15       Impact factor: 47.728

Review 4.  Immunologic interactions of T lymphocytes with vascular endothelium.

Authors:  J S Pober; R S Cotran
Journal:  Adv Immunol       Date:  1991       Impact factor: 3.543

Review 5.  Mature T lymphocyte apoptosis--immune regulation in a dynamic and unpredictable antigenic environment.

Authors:  M Lenardo; K M Chan; F Hornung; H McFarland; R Siegel; J Wang; L Zheng
Journal:  Annu Rev Immunol       Date:  1999       Impact factor: 28.527

6.  Cloning, expression and significance of MPT53 for identification of secreted proteins of Mycobacterium tuberculosis.

Authors:  H G Wiker; S L Michell; R G Hewinson; E Spierings; S Nagai; M Harboe
Journal:  Microb Pathog       Date:  1999-04       Impact factor: 3.738

7.  In situ expression of cytokines and cellular phenotypes in the lungs of mice with slowly progressive primary tuberculosis.

Authors:  T Mustafa; S Phyu; R Nilsen; R Jonsson; G Bjune
Journal:  Scand J Immunol       Date:  2000-06       Impact factor: 3.487

Review 8.  Adenosine - cyclic AMP pathways and cytokine expression.

Authors:  Z Zidek
Journal:  Eur Cytokine Netw       Date:  1999-09       Impact factor: 2.737

9.  Loss of CCR2 expression and functional response to monocyte chemotactic protein (MCP-1) during the differentiation of human monocytes: role of secreted MCP-1 in the regulation of the chemotactic response.

Authors:  L Fantuzzi; P Borghi; V Ciolli; G Pavlakis; F Belardelli; S Gessani
Journal:  Blood       Date:  1999-08-01       Impact factor: 22.113

10.  Differential modulation of annexin I binding sites on monocytes and neutrophils.

Authors:  H S Euzger; R J Flower; N J Goulding; M Perretti
Journal:  Mediators Inflamm       Date:  1999       Impact factor: 4.711

View more
  7 in total

Review 1.  Perspectives on clinical and preclinical testing of new tuberculosis vaccines.

Authors:  Arthur M Dannenberg
Journal:  Clin Microbiol Rev       Date:  2010-10       Impact factor: 26.132

2.  Expression of L-Selectin (CD62L), CD44, and CD25 on activated bovine T cells.

Authors:  W R Waters; T E Rahner; M V Palmer; D Cheng; B J Nonnecke; D L Whipple
Journal:  Infect Immun       Date:  2003-01       Impact factor: 3.441

3.  BCG-induced rabbit alveolar macrophages are endowed with strengthened antioxidant metabolic pathways.

Authors:  Francesca Vita; Rita Abbate; Violetta Borelli; Cristiana Brochetta; Maria Rosa Soranzo; Giuliano Zabucchi
Journal:  Inflammation       Date:  2007-10-02       Impact factor: 4.092

Review 4.  A spotlight on liquefaction: evidence from clinical settings and experimental models in tuberculosis.

Authors:  Pere-Joan Cardona
Journal:  Clin Dev Immunol       Date:  2011-03-13

5.  Correlation between Serum Level of Monocyte Chemoattractant Protein-1 and Postoperative Recurrence of Spinal Tuberculosis in the Chinese Han Population.

Authors:  Dan He; Xiaolu Zhang; Qile Gao; Rongfu Huang; Zhansheng Deng; Chaofeng Guo; Qiang Guo; Jia Huang; Hongqi Zhang
Journal:  PLoS One       Date:  2015-05-11       Impact factor: 3.240

6.  Perspectives for Developing New Tuberculosis Vaccines Derived from the Pathogenesis of Tuberculosis: I. Basic Principles, II. Preclinical Testing, and III. Clinical Testing.

Authors:  Arthur M Dannenberg; Bappaditya Dey
Journal:  Vaccines (Basel)       Date:  2013-01-25

7.  Transcript levels of major interleukins in relation to the clinicopathological profile of patients with tuberculous intervertebral discs and healthy controls.

Authors:  Chong Liu; Xinli Zhan; Zengming Xiao; Qie Fan; Li Deng; Mingxing Cui; Chunxiang Xiong; Jingbo Xue; Xiangtao Xie
Journal:  PLoS One       Date:  2014-06-27       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.